Pharmaceutical
Pfizer’s Leukemia Drug Receives Green Light from FDA
The U.S. Food and Drug Administration officially approved Pfizer Inc’s (NYSE:$PFE) drug, Mylotarg, for the treatment of myeloid leukemia. The drug was given the green ligt to treat adults with newly diagnosed AML whose tumors ... [Read]
Retail
Why You Should Invest in Lululemon Today
Ever heard of the saying, “more than just a pretty face”? Lululemon Athletica (NASDAQ:$LULU) is a leading competitor in the athleisure retail space, and revealed a more than impressive earning report yesterday. The company attributed much ... [Read]
Tech
Why the Market Is Having a Headache Over Intel
With 56% of analysts recommending a “buy” option, 35% recommending a “hold”, and 8% recommending a “sell”, the outlook on Intel Corporation (NASDAQ:$INTC) seems divided to say the least. Perhaps a trend in the semiconductor ... [Read]
Consumer
The Era Of Ad Revenue: Time Warner’s Tactics
For a mass media conglomerate like Time Warner (NASDAQ:$TWX), advertising is a fundamental resource of generating revenue. In fact, AT&T (NASDAQ:$T) is looking to acquire Time Warner by the end of this year. The telecommunications ... [Read]